Business

FinnCap’s latest Rude Health Life Sciences Sector Report focuses on the implications of early COVID-19 vaccine data. This comes as Pfizer and BioNTech have announced their COVID-19 vaccine candidate has so far been found to be 90% effective in preventing COVID-19. Mark Brewer, Director of Research for finnCap, commented: “While the results are very promising, we […]

Dr. Steve Arlington and Dr. Nick Lynch, The Pistoia Alliance, provide insight into pre-competitive collaboration and data sharing as we thinks about R&D beyond the pandemic  At the Pistoia Alliance, our mission is to encourage collaboration across the life sciences ecosystem. We believe that scientific advances and breakthroughs cannot be made alone and require the […]

Does every cloud have a silver lining? Dr Phil Jones, Chief Scientific Officer, BioAscent Discovery outlines the opportunities for lead generation and the acquisition of compound screening libraries. The discovery of novel medicines is a complex but vital endeavour. The range of approaches being used to identify those new medicines is ever widening with, for […]

COVID-19 has shown the pace of innovation that is possible to develop vaccines and therapeutics. Matt Jones, Lead Data Scientist Strategist, Tessella explains how to set up R&D and data science teams to keep that going. The drive to develop new therapeutics and vaccines for COVID-19 saw researchers move at unprecedented speeds. Years became months, […]

By Dr Ross Macdonald Cell-based therapies are being widely recognised for their potential to treat a variety of medical conditions, but they face major obstacles toward commercialisation. Traditionally, they have been difficult and expensive to make in large quantities. Biopharmaceutical companies must develop manufacturing solutions that will enable them to efficiently and reproducibly create the […]